Symbiotec Pharmalab IPO
Allotment Status
Registrar: MUFG Intime India
Issue price
₹988
Listing price
₹988
Last GMP (₹)
₹250
GMP estimate
+25.30%
Actual listing gain
+0.00%
Return per lot
+₹0
GMP vs listing performance
GMP pointed to +25.30% but the stock listed at +0.00% — 25.3% lower than estimated.
Listing gain calculator
Estimate profit or loss based on actual listing performance
- Investment
- ₹14,820
- Listing value
- ₹14,820
- Listing gain
- +0.00%
- Profit (1 lot)
- +₹0
Based on issue price ₹988 × 15 shares per lot. Listing price ₹988. Excludes taxes, DP charges, and selling costs.
Listing results from exchange debut data where recorded. See GMP accuracy report · How we track this
Symbiotec Pharmalab IPO — Quick Analysis
Symbiotec Pharmalab IPO listed on 1 Sept 2026 at an issue price of ₹988, gained 0.0% on listing day. It listed near its issue price. The issue was subscribed 75.08x overall.
Overview
Symbiotec Pharmalab is a recently listed Mainboard IPO in India, raising ₹1757.00 Cr, with shares offered around ₹988. The stock has listed with a +0.0% debut move versus the issue price. For business fundamentals, revenue trends, and use of proceeds, read the RHP on SEBI or NSE/BSE — we summarise market metrics, not audited financials.
GMP and subscription figures are unofficial market data, refreshed twice daily for active IPOs. Last updated 27 Aug 2026, 05:54 pm IST. How we source data · Disclaimer
Strengths
- Subscribed 75.08x — strong demand.
- Positive GMP of ₹250 (+25.3%).
- Mainboard listing — deeper liquidity on NSE/BSE.
Risks
- Listing price can fall below issue price despite positive GMP.
- GMP is unofficial — not a confirmed listing outcome.
FAQ
Symbiotec Pharmalab IPO questions
- What is Symbiotec Pharmalab IPO price?
- ₹988 per share. Confirm in the RHP before applying.
- What is Symbiotec Pharmalab IPO GMP?
- ₹250 (+25.3%). Unofficial — changes daily.
- When is Symbiotec Pharmalab allotment?
- Expected around 28 Aug 2026. Check the registrar link on this page.